Market Research Report
Structural Biology Market with COVID-19 Impact Analysis, By Product, By Application, and By Region - Size, Share, & Forecast from 2021-2027
|Published by||AnalystView Market Insights||Product code||997948|
|Published||Content info||288 Pages
Delivery time: 2-3 business days
|Structural Biology Market with COVID-19 Impact Analysis, By Product, By Application, and By Region - Size, Share, & Forecast from 2021-2027|
|Published: February 1, 2021||Content info: 288 Pages||
The global structural biology market was valued at USD 4.56 billion in 2020, growing with 16.4% CAGR during the forecast period, 2021-2027.
Structural Biology involves the analysis of three-dimensional (3D) structures in biological macromolecules. Several molecular modeling methods are used to find out issues in structural biology. These molecular modeling techniques are an integral part of structure determination.
The structural biology market is estimated to witness significant growth in the next few years, owing to the growing prevalence of chronic diseases, and a rising number of drug development is expected to boost the market growth. In addition, the growing need for advanced therapeutics is expected to gain momentum over the forecast period. For example, in 2011, the University of Natural Resources in Austria has carried out simulations in molecular dynamics for measuring activities of humanized antibodies (Ab2). This is also used to neutralize HIV-1. Thus, the increasing number of drug development and drug trials are expected to foster market growth.
Furthermore, the rising innovation in technologies is enabling the determination of cellular function, structure which aids to identify novel drugs. Moreover, the rapid development in bioinformatics and increasing demand for modeling methods for reducing drug failure chances are anticipated to positively impact the market growth. These novel drugs help to improve biomedical research & optimizing the drug discovery process. The drug design firms are investing in modeling techniques or projects to predict the structure of new drugs & the presence of molecular components. The 3D molecular structure helps to better understand biological interaction with detailed insights.
The structural biology market is fragmented into product, and application segments. Based on the product, the SaaS and standalone modeling type segment dominated the market with the highest market share in 2019. On the other side, the drug discovery segment is estimated to offer potential growth opportunities for the structural biology market.
In 2019, North America dominated the overall market with the largest market share. The rising focus on new & advanced drugs by the key players is expected to propel the market growth. Moreover, the growing spending in the R&D development in the U.S. is also driving the market growth. For example, American Diabetes Association (ADA), has introduced a research forum in partnership with Entelos. Asia Pacific is anticipated to grow at the highest CAGR over the forecast period. The presence of a large number of contract research organizations is mainly contributing to regional growth.
The structural biology market is differentiated with the presence of international players and regional players. The market is highly competitive in nature. Key companies in the industry mainly focus on new product launches, R&D development, and developing innovative technological solutions. For example, Dassault Systems continuously invest in R&D unit to develop new software or tools for drug discovery methods.
Key features of the study:
This proposed research study on Structural Biology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2020-2027), considering 2019 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Structural Biology market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Structural Biology market
Impact of COVID-19 on Structural Biology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Structural Biology market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Structural Biology market, we have also included competitive landscape and key innovator analysis for the Structural Biology market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and end-user's attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Structural Biology market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new product launch, research & development, regional expansion of major participants involved in the Structural Biology market on global as well as regional level.
The global Structural Biology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL STRUCTURAL BIOLOGY MARKET KEY PLAYERS
Agilent Technologies, Inc.
Biomax Informatics AG
Chemical Computing Group
GLOBAL STRUCTURAL BIOLOGY MARKET, BY PRODUCT
SaaS and Standalone Modelling
Visualization and Analysis
GLOBAL STRUCTURAL BIOLOGY MARKET, BY APPLICATION
GLOBAL STRUCTURAL BIOLOGY MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA
List of Tables
List of Figures